Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
It is intended solely for laboratory use and in vitro studies, not for human or animal consumption
They must not be taken alongside MAOIs
The CMS reform eliminating point-of-sale DIR adjustments in Part D beginning January 2024 addresses the retroactive uncertainty but does not address below-cost base reimbursement in commercial contracts
Every patient is unique, and during our consultation process, we work with you to develop a bespoke treatment plan based on what you want to achieve
US$ 22.06
US$ 22.13
US$ 26.89
US$ 20.09
